T. Rowe Price Investment Management, Inc.

Holdings History for Apogee Therapeutics, Inc. - COMMON STOCK (APGE)

Symbol: APGE on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 6,213,827 shares
Security Ownership %: 11%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Investment Management, Inc. ownership in Apogee Therapeutics, Inc. COMMON STOCK (APGE)

06 Mar 2026 - T. Rowe Price Investment Management, Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,213,827 shares of Apogee Therapeutics, Inc. COMMON STOCK (APGE). This represents 11% ownership of the company. This is the first filing by T. Rowe Price Investment Management, Inc. disclosing ownership of Apogee Therapeutics, Inc. COMMON STOCK (APGE).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
T. Rowe Price Investment Management, Inc.	11%		$408,931,955	6,213,827			$65.81	13G	28 Feb 2026	06 Mar 2026, 12:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.13%	+0.22%	$206,246,000	2,732,456	+2,731,015	+189522%	$75.48	Q4 2025
30 Sep 2025	0%	+0%	$58,000	1,441	+977	+211%	$40.25	Q3 2025
30 Jun 2025	0%	+0%	$21,000	464	+464	NEW	$45.26	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.